Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy.
A case is reported of a severe postpartum maternal hemorrhagic complication, which was related to prophylactic antithrombotic therapy with daily low-dose aspirin (75 mg) combined with dipyridamole (225 mg) for the prevention of preeclampsia. The postpartum course was complicated by recurrent episiotomy site hematomas of nonclotted blood and prolonged bleeding time. Transfusion of platelet concentrates was necessary to control the bleeding. This case report draws attention to maternal hemorrhagic complications which may be associated with prophylactic low-dose aspirin and dipyridamole in pregnancy.
Reubinoff
B E
BE
Department of Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem, Israel.
Eldor
A
A
Laufer
N
N
Sadovsky
E
E
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D001760:Bleeding Time; D016913:Blood Component Transfusion; D001803:Blood Transfusion; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006473:Postpartum Hemorrhage / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000517:prevention & control; D011247:Pregnancy
D006454:Hemoglobins; D004176:Dipyridamole; D001241:Aspirin